• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

3 Deep-Value Plays

Putting Benjamin Graham's principles into practice
By TIM MELVIN Apr 21, 2015 | 02:00 PM EDT
Stocks quotes in this article: LF, EMKR, RELL

The merits of Benjamin Graham's net-current-asset approach to investing have been pointed out many times. The merits of owning companies that sell in the marketplace for less than current assets minus all liabilities are well demonstrated. And yet very few people use this successful cigar-butt approach to investing in stocks. Net-current-asset stocks tend to be small, unloved companies that haven't fared well in the recent past. 

The net-current-asset approach can lag the market for long periods of time. The returns are beyond lumpy. In the 1990s, as stocks rose consistently, the strategy underperformed in seven of the 10 years. It is hard to stick with an approach underperforming that badly, but during the next three years, the strategy more than tripled investors' money as the rest of the market collapsed.

The best way to use these stocks is as part of a broader deep-value portfolio. It is difficult most years to find enough stocks to be fully invested unless you want to run a highly concentrated portfolio of cigar butts. I like to own lots of safe and cheap stocks, and I generally avoid high levels of concentration, and so I consider net-current-asset-value stocks to be one more tool in the shed.

This morning, I ran a screen looking for net- net stocks that might be worth consideration. As you might expect, there are not many now, and most of what I found is very small. The majority of stocks trading at a discount to net current asset value, or NCAV, were tiny, but I did find one larger net-current-asset bargain worth buying and several interesting companies that are worth considering as bargain issues.

When I first talked about LeapFrog  (LF) earlier this year, I said that either the company would get its act together this past holiday season and the stock would soar, or the company would continue to underperform and mismanage inventories and it would collapse. The latter scenario played out, and the stock has tumbled. The stock is now a cigar-butt bargain issue that trades at just 76% net current asset. I don't know what will happen to LeapFrog. I just hope management will wake up and realize the company knows how to make great educational toys, but not so much about running a business, and will sell out to a larger toy or educational products company. Management could probably liquidate the company at a profit at current prices, and so it is worth adding to any current position or establishing one if you have not done so.

Emcore (EMKR) is an interesting company that trades for just a little bit more than net current asset values at the current price. It makes semiconductors and systems for the fiber-optics and broadband markets. The company is seeing decent sales and earnings growth this year, and is being pretty much ignored by investors. The stock popped higher last year after the company sold its space photovoltaics business for $150 million. Small-cap activist manager Becker Drapkin has a 10% stake, and several other noted value and small-cap growth specialists also own shares. The future looks pretty solid for Emcore, and the stock should trade higher compared with asset value than it does now. It is not a pure net-net stock, but it is an intriguing issue.

Richardson Electronics (RELL) is on the list again as it trades at just 87% of net current asset value. I strongly suspect that this will be one of those stocks that is a long-term frustration, leading many to sell just before it triples in value. The company makes electronic components and display systems, and business has been just average for a few years now. Richardson has been investing in a new information-technology platform and has been building out Richardson Healthcare for the past years, which has been a drag on profits and cash flow. The stocks yields 2.76%, and management has been buying back stock, trying to reward patient shareholders.

There are not a lot of net-current-asset a bargains available, but a few that trade for less -- or in the case of Emcore, just a little more -- than NVAC, are worth further investigation by patient aggressive investors.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Melvin was long LF and RELL.

TAGS: Investing | U.S. Equity

More from Investing

Marveling at the Market's Move? It's All About Momentum

James "Rev Shark" DePorre
Jan 19, 2021 4:41 PM EST

No news can explain the action -- whether the bears believe it or not.

Surface Oncology Is Set for Further Gains - How to Buy It

Bruce Kamich
Jan 19, 2021 3:25 PM EST

Here's our price objective.

My Preference With OneSpan Is Calls So I Can Define My Risk

Timothy Collins
Jan 19, 2021 2:36 PM EST

The last few post-earnings beat downs were greeted with optimism once traders got over the initial disappointment.

A Top Biotechnology Play for 2021

James "Rev Shark" DePorre
Jan 19, 2021 2:07 PM EST

Forte's sole clinic candidate is FB-401 for the treatment of atopic dermatitis, which is the scientific name for eczema.

Boot Barn Gets a Quant Upgrade: Do the Charts Fit?

Bruce Kamich
Jan 19, 2021 1:53 PM EST

Here's our latest analysis and trading strategy for the shares.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:09 AM EST GARY BERMAN

    Is Copper About to Turn to Rust?

    Below is a very long-term copper chart.  As you...
  • 08:02 AM EST GARY BERMAN

    Tuesday Morning Fibocall for for 1/19/2021

    SPX (Long-Term View) The 1/8/21 high @ 3826.69 i...
  • 09:01 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    When it's time to sell, will you act or freeze?
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login